For This Week in Cardiology Setpember 25, 2015, Dr John Mandrola comments on the following cardiology news and features stories:
Diabetes Drug Empagliflozin Cuts CV Deaths in Landmark EMPA-REG Trial
TEXT ME: Lifestyle-Modification App May Improve LDL Cholesterol, Other CVD Risk Factors
Cohorts, Meta-Analysis: No Link Between Coffee and Increased Risk for Atrial Fibrillation
Features:
Chief Cardiology Correspondent
John M Mandrola, MD, Clinical Electrophysiologist, Baptist Medical Associates, Louisville, Kentucky
Disclosure: John M Mandrola, MD, reports no relevant financial relationships.
© 2015 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Sep 25 Cardiology News Podcast - Medscape - Sep 25, 2015.
Comments